Skip to main content
Equibles

Woodline Partners LP

Position in PGEN — Precigen, Inc.

CIK 1784547 San Francisco, CA
Back to PGEN Full portfolio

Position in PGEN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$7,991,086
+$2,567,622 QoQ
Shares Held
1,401,945
+0.0% QoQ
Ownership
0.392%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#20
of 210 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PGEN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Woodline Partners LP holds $4,400,572,274 across 197 Biotechnology names. PGEN ranks #109 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 2,002,863 $375,096,182
2 PTGX
Protagonist Therapeutics, Inc
 1,414,173 $173,349,326
3 TNGX
Tango Therapeutics, Inc.
 4,000,567 $125,057,724
4 BHVN
Biohaven Ltd.
 7,660,280 $113,984,966
5 COGT
Cogent Biosciences, Inc.
 2,603,162 $100,742,369
6 CYTK
Cytokinetics Inc
 1,100,708 $93,769,314
7 RCUS
Arcus Biosciences, Inc.
 3,007,798 $92,730,412
8 ROIV
Roivant Sciences Ltd.
 2,500,673 $88,498,817

All Filings in PGEN

Export CSV
3 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $7,991,086 1,401,945
2026-03-31 $5,423,464 1,401,412
2025-12-31 $5,856,016 1,400,961